Creatinine Test Market Research Report - Global Forecast till 2027

Creatinine Test Market: Information by Test Type (Blood Test, Urine Test and Creatinine Clearance Test), Product Type (Consumables and Instruments), Application (Urinary Tract Obstruction, Renal Failure, Kidney Cancer and Glomerulonephritis), End User (Hospital and Clinics, Diagnostic Centre and Research Institutes) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

ID: MRFR/LS/3449-CR | July 2019 | Region: Global | 188 pages

Creatinine Test Market Overview


The Creatinine Test Market is expected to register a CAGR of 5.80% and is anticipated to reach USD 604.55 Million by 2023. Creatinine testing is used to monitor progression and treatment of acute kidney injury and chronic kidney disease (CKD). It is basically of three types, namely, serum creatinine test, urine test, and creatinine clearance test. Serum creatinine is combined with measurements of urine creatinine to generate the creatinine clearance, an indicator of the glomerular filtration rate (GFR). Serum creatinine can also be used together with demographic information to calculate an estimated GFR (eGFR).


Prevalence of chronic kidney disease, technological advancements in the kidney function testing, initiatives taken by the government to control chronic kidney diseases are the major drivers propelling market growth. However, false estimates of creatinine testing may constrain the growth of the market.


Market Dynamics


Prevalence of chronic kidney disease, technological advancements in the kidney function testing, initiatives taken by the government to control chronic kidney diseases are the factors that boost the growth of the market. For instance, in February 2018, Siemens Healthineers received an FDA approval for its blood urea nitrogen (BUN) and total carbon dioxide (TCO2) point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances. Whereas false estimates of creatinine testing may constrain the growth of the market.


Creatinine Test Market Size, by Product Type, 2016 & 2023 (USD Million)  Creatinine Test Market


Source: MRFR Analysis


Segmentation


The creatinine test market has been segmented into test type, product type, application, the end user. Based on test type, the market has been segmented into a blood test, urine test, and creatinine test. Based on product type, the market has been divided into consumables and instruments. The consumables segment held a market share of 238.96 in 2016. Based on application, the market has been segregated into urinary tract obstruction, renal failure, kidney failure, and glomerulonephritis. Based on end user, the market has been bifurcated into hospital and clinics, diagnostic center, and research institutes.


Key Players


The prominent players in the creatinine test market are Siemens, Abbott, Thermo Fisher Scientific Inc., Roche, and Danaher.


Some of the key strategies followed by the players operating in the creatinine test market were acquisitions, collaborations and partnerships, product launches, and others.


Asia-Pacific Creatinine Test Market Share, by Country, 2016 (%)  Creatinine Test Market


Source: MRFR Analysis


Regional Analysis


The creatinine test market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to dominate the creatinine test market during the forecast period. This is attributed to the rising prevalence of various kidney diseases, well-developed technology, high healthcare expenditure, and the presence of leading players. Europe accounts for the second-largest creatinine market. The major driving factors of the market are increasing government support, rising healthcare expenditure, and well-developed technology.


Asia-Pacific is estimated to be the fastest-growing market due to the increasing demand for early diagnosis, rapidly improving technology, and the presence of a vast patient pool. The initiatives taken by the government to control chronic kidney diseases are also boosting the growth of the market. China held a market share of 22.6% in 2016. Furthermore, the market in the Middle East & Africa is expected to hold the least share in the market owing to the presence of poor and slow developing countries, especially in the African region.


Key Updates



  • In February 2018, Siemens Healthineers received an FDA approval for its Blood Urea Nitrogen (BUN) and Total Carbon Dioxide (TCO2) point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances



  • In November 2017, F Hoffmann-La Roche Ltd acquired Viewics, Inc. to expand its leading position in the Integrated Core Lab with business analytics capabilities.



  • In August 2017, Nova Biomedical gained the CE mark certification for Stat Profile Prime Plus and is now available in all CE regulated countries.


Market Segmentation


Creatinine Test Market, by Test Type



  • Blood Test

  • Urine Test

  • Creatinine Clearance Test


Creatinine Test Market, by Product Type



  • Consumables

  • Instruments


Creatinine Test Market, by Application



  • Urinary Tract Obstruction

  • Renal Failure

  • Kidney Cancer

  • Glomerulonephritis


Creatinine Test Market, by End User



  • Hospital & Clinics

  • Diagnostic Centre

  • Research Institutes


Creatinine Test Market, by Region



  • Americas


    • North America


      • US

      • Canada


    • South America




  • Europe


    • Western Europe

    • Germany

    • UK

    • Italy

    • Spain

    • Rest of Western Europe

    • Eastern Europe




  • Asia-Pacific


    • China

    • Japan

    • India

    • Australia

    • Republic of Korea

    • Rest of Asia-Pacific




  • Middle East & Africa


    • Middle East

    • Africa



Available Additional Customizations



  • Additional Companies


    • BioAssay Systems

    • Abcam PLC

    • Arbor Assays

    • Randox Laboratories Ltd

    • DiaSys Diagnostic Systems GmbH

    • MedTest Holdings, Inc. (Pointe Scientific, Inc.)


  • Challenges in Creatinine Market


Intended Audience



  • Medical device manufacturers and distributors

  • Government research organizations

  • Hospitals and clinics

  • Regulatory agencies

  • Pharmaceutical companies



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


Creatinine test market projected to grow at approximately 5.80% CAGR during the assessment period (2020-2027).

The valuation of the global creatinine test market is estimated to increase to USD 604.55 MN by the end of 2023.

Increasing demand for diagnosis of kidney disease and rising healthcare expenses are major tailwinds pushing the growth of the global creatinine test market.

North America holds the largest share in the global creatinine test market, followed by Europe and the Asia Pacific, respectively.

Merck (U.S.), Quest Diagnostics (U.S.), Sonic Healthcare (Australia), Beckman Coulter (U.S.), Bayer (U.S.), Laboratory Corporation of America Holdings (U.S.), Healthscope (Australia), Genoptix (U.S.), Labco (Kuwait), OPKO Health, Inc. (U.S.), Charles River (U.S.), and Abbott (U.S.), are some of the top players operating in the global creatinine test market.

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 23

3.2 Scope Of The Study 23

3.3 Assumptions & Limitations 23

3.3.1 Assumptions 23

3.3.2 Limitations 23

3.4 Market Structure 24

4 Research Methodology

4.1 Research Process 26

4.2 Primary Research 27

4.3 Secondary Research 28

4.4 Market Size Estimation 29

4.5 Forecast Model 29

5 Market Dynamics

5.1 Introduction 31

5.2 Drivers 32

5.2.1 Prevalence Of Chronic Kidney Disease 32

5.2.2 Technological Advancements In The Kidney Function Testing 32

5.2.3 Initiatives Taken By Government To Control Chronic Kidney Diseases 33

5.3 Restraints 33

5.3.1 False Estimates Of Creatinine Testing 33

5.4 Opportunities 33

5.4.1 Rising Approval From FDA 33

5.5 Macroeconomic Indicators 34

6 Market Factor Analysis

6.1 Supply Chain Analysis 36

6.1.1 R&D 36

6.1.2 Parts Manufacturing 36

6.1.3 Distribution 36

6.1.4 Marketing & Sales 36

6.1.5 Post–Sales Monitoring 36

6.2 Demand & Supply: Gap Analysis 37

6.3 Pricing Analysis 37

6.4 Investment Opportunities 37

6.5 Porter’s Five Forces Model 38

6.5.1 Bargaining Power Of Suppliers 38

6.5.2 Bargaining Power Of Buyers 38

6.5.3 Threat Of New Entrants 39

6.5.4 Threat Of Substitutes 39

6.5.5 Intensity Of Rivalry 39

7 Creatinine Test Market, By Test Type

7.1 Overview 41

7.1.1 Blood Test 41

7.1.2 Urine Test 41

7.1.3 Creatinine Clearance Test 41

8 Creatinine Test Market, By Product Type

8.1 Overview 46

8.1.1 Consumables 46

8.1.2 Instruments 46

9 Creatinine Test Market, By Application

9.1 Overview 51

9.1.1 Urinary Tract Obstruction 51

9.1.2 Renal Failure 51

9.1.3 Kidney Cancer 51

9.1.4 Glomerulonephritis 51

10 Creatinine Test Market, By End User

10.1 Overview 55

10.1.1 Hospital & Clinics 55

10.1.2 Diagnostic Centre 55

10.1.3 Research Institutes 55

11 Creatinine Test Market, By Region

11.1 Introduction 59

11.2 Americas 61

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.2.1 North America 65

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.2.1.1 US. 68

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.2.1.2 Canada 71

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.2.2 South America 74

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.3 Europe 78

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.3.1 Western Europe 82

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.3.1.1 Germany 85

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.3.1.2 UK 91

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.3.1.3 Italy 94

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.3.1.4 Spain 97

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.3.1.5 Rest Of Western Europe 100

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.3.2 Eastern Europe 103

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.4 Asia–Pacific 107

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.4.1 Japan 111

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.4.2 China 114

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.4.3 India 117

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.4.4 Australia 120

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.4.5 South Korea 123

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.4.6 Rest Of Asia–Pacific 126

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.5 The Middle East And Africa 130

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.5.1 Middle East 134

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

11.5.2 Africa 137

Creatinine Test Market, By Test Type

Creatinine Test Market, By Product Type

Creatinine Test Market, By Application

Creatinine Test Market, By End User

12 Competitive Landscape

12.1 Company Market Share Analysis 141

12.1.1 Introduction 141

12.2 Competitive Landscape 142

12.2.1 Introduction 142

12.3 Key Developments 143

13 Company Profiles

13.1 Siemens AG 145

13.1.1 Company Overview 145

13.1.2 Financial Overview 145

13.1.3 Products Offerings 146

13.1.4 Key Developments 146

13.1.5 SWOT Analysis 146

13.1.6 Key Strategy 147

13.2 Abbott 148

13.2.1 Company Overview 148

13.2.2 Financial Overview 148

13.2.3 Products Offerings 148

13.2.4 Key Developments 149

13.2.5 SWOT Analysis 149

13.2.6 Key Strategy 149

13.3 Thermo Fisher Scientific Inc 150

13.3.1 Company Overview 150

13.3.2 Financial Overview 150

13.3.3 Products Offerings 151

13.3.4 Key Developments 151

13.3.5 SWOT Analysis 151

13.3.6 Key Strategy 151

13.4 Abcam PLC 152

13.4.1 Company Overview 152

13.4.2 Financial Overview 152

13.4.3 Products Offerings 152

13.4.4 Key Developments 153

13.4.5 SWOT Analysis 153

13.4.6 Key Strategy 153

13.5 F. Hoffmann–La Roche AG 154

13.5.1 Company Overview 154

13.5.2 Financial Overview 154

13.5.3 Products Offerings 155

13.5.4 Key Developments 155

13.5.5 SWOT Analysis 155

13.5.6 Key Strategy 155

13.6 Nova Biomedical 156

13.6.1 Company Overview 156

13.6.2 Products Offerings 156

13.6.3 Key Developments 156

13.6.4 SWOT Analysis 157

13.6.5 Key Strategy 157

13.7 ACON Laboratories, Inc. 158

13.7.1 Company Overview 158

13.7.2 Products Offerings 158

13.7.3 Key Developments 158

13.7.4 SWOT Analysis 158

13.7.5 Key Strategy 158

13.8 OPTI Medical Systems 159

13.8.1 Company Overview 159

13.8.2 Products Offerings 159

13.8.3 Key Developments 159

13.8.4 SWOT Analysis 159

13.8.5 Key Strategy 159

13.9 URIT Medical 160

13.9.1 Company Overview 160

13.9.2 Products Offerings 160

13.9.3 Key Developments 160

13.9.4 SWOT Analysis 160

13.9.5 Key Strategy 160

13.10 Quest Diagnostics 161

13.10.1 Company Overview 161

13.10.2 Financial Overview 161

13.10.3 Products Offerings 162

13.10.4 Key Developments 162

13.10.5 SWOT Analysis 162

13.10.6 Key Strategy 162

13.11 ARKRAY, Inc. 163

13.11.1 Company Overview 163

13.11.2 Products Offerings 163

13.11.3 Key Developments 163

13.11.4 SWOT Analysis 163

13.11.5 Key Strategy 163

13.12 Danaher 164

13.12.1 Company Overview 164

13.12.2 Products Offerings 165

13.12.3 Key Developments 165

13.12.4 SWOT Analysis 165

13.12.5 Key Strategy 165

14 Conclusion

14.1 Key Findings 167

14.1.1 CEO’s Viewpoint 167

14.1.2 Unmet Needs 167

14.1.3 Key Companies To Watch 167

14.1.4 Prediction 167

15 Appendix

15.1 Discussion Blue Print 169

15.2 References 170

16 List Of Tables

TABLE 1 MARKET SYNOPSIS 21

TABLE 2 PRIMARY INTERVIEWS 27

TABLE 3 GLOBAL CREATININE TEST MARKET FOR BLOOD TEST, BY REGION 2020–2027 (USD MILLION) 42

TABLE 4 GLOBAL CREATININE TEST MARKET FOR SERUM CREATININE TEST, BY REGION 2020–2027 (USD MILLION) 42

TABLE 5 GLOBAL CREATININE TEST MARKET FOR EGFR TEST, BY REGION 2020–2027 (USD MILLION) 43

TABLE 6 GLOBAL CREATININE TEST MARKET FOR BLOOD UREA NITROGEN TEST, BY REGION 2020–2027 (USD MILLION) 43

TABLE 7 GLOBAL CREATININE TEST MARKET FOR URINE TEST, BY REGION 2020–2027 (USD MILLION) 43

TABLE 8 GLOBAL CREATININE TEST MARKET FOR A: C TEST, BY REGION 2020–2027 (USD MILLION) 44

TABLE 9 GLOBAL CREATININE TEST MARKET FOR P: C TEST, BY REGION 2020–2027 (USD MILLION) 44

TABLE 10 GLOBAL CREATININE TEST MARKET FOR CREATININE CLEARANCE TEST, BY REGION 2020–2027 (USD MILLION) 44

TABLE 11 GLOBAL CREATININE TEST MARKET FOR CONSUMABLE, BY REGION 2020–2027 (USD MILLION) 47

TABLE 12 GLOBAL CREATININE TEST MARKET FOR URINE TEST STRIPS, BY REGION 2020–2027 (USD MILLION) 47

TABLE 13 GLOBAL CREATININE TEST MARKET FOR CARTRIDGE, BY REGION 2020–2027 (USD MILLION) 47

TABLE 14 GLOBAL CREATININE TEST MARKET FOR INSTRUMENTS, BY REGION 2020–2027 (USD MILLION) 48

TABLE 15 GLOBAL CREATININE TEST MARKET FOR CLINICAL ANALYZER, BY REGION 2020–2027 (USD MILLION) 48

TABLE 16 GLOBAL CREATININE TEST MARKET FOR BENCH TOP CLINICAL ANALYZER, BY REGION 2020–2027 (USD MILLION) 48

TABLE 17 GLOBAL CREATININE TEST MARKET FOR AUTOMATED, BY REGION 2020–2027 (USD MILLION) 49

TABLE 18 GLOBAL CREATININE TEST MARKET FOR SEMI AUTOMATED, BY REGION 2020–2027 (USD MILLION) 49

TABLE 19 GLOBAL CREATININE TEST MARKET FOR HANDHELD CLINICAL ANALYZER, BY REGION 2020–2027 (USD MILLION) 49

TABLE 20 GLOBAL CREATININE TEST MARKET FOR URINARY TRACT OBSTRUCTION, BY REGION 2020–2027 (USD MILLION) 52

TABLE 21 GLOBAL CREATININE TEST MARKET FOR RENAL FAILURE, BY REGION 2020–2027 (USD MILLION) 52

TABLE 22 GLOBAL CREATININE TEST MARKET FOR KIDNEY CANCER, BY REGION 2020–2027 (USD MILLION) 53

TABLE 23 GLOBAL CREATININE TEST MARKET FOR GLOMERULONEPHRITIS, BY REGION 2020–2027 (USD MILLION) 53

TABLE 24 GLOBAL CREATININE TEST MARKET FOR HOSPITAL & CLINICS, BY REGION 2020–2027 (USD MILLION) 56

TABLE 25 GLOBAL CREATININE TEST MARKET FOR DIAGNOSTIC CENTER, BY REGION 2020–2027 (USD MILLION) 56

TABLE 26 GLOBAL CREATININE TEST MARKET FOR RESEARCH INSTITUTES, BY REGION 2020–2027 (USD MILLION) 57

TABLE 27 GLOBAL CREATININE TEST MARKET, BY REGION, 2020–2027 (USD MILLION) 59

TABLE 28 AMERICAS: CREATININE TEST MARKET, BY REGION, 2020–2027 (USD MILLION) 61

TABLE 29 AMERICAS: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 62

TABLE 30 AMERICAS CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 62

TABLE 31 AMERICAS CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 62

TABLE 32 AMERICAS: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 62

TABLE 33 AMERICAS: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 34 AMERICAS: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 35 AMERICAS: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 36 AMERICAS: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 37 AMERICAS: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 64

TABLE 38 AMERICAS: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 64

TABLE 39 NORTH AMERICA: CREATININE TEST MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 65

TABLE 40 NORTH AMERICA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 65

TABLE 41 NORTH AMERICA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 65

TABLE 42 NORTH AMERICA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 43 NORTH AMERICA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 66

TABLE 44 NORTH AMERICA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 45 NORTH AMERICA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 46 NORTH AMERICA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 67

TABLE 47 NORTH AMERICA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 67

TABLE 48 NORTH AMERICA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 67

TABLE 49 NORTH AMERICA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 68

TABLE 50 US: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 68

TABLE 51 US: CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 52 US: CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 69

TABLE 53 US: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 69

TABLE 54 US: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 69

TABLE 55 US: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 69

TABLE 56 US: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 57 US: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 58 US: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 70

TABLE 59 US: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 71

TABLE 60 CANADA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 71

TABLE 61 CANADA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 71

TABLE 62 CANADA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 63 CANADA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 72

TABLE 64 CANADA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 65 CANADA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 66 CANADA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 67 CANADA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 68 CANADA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 73

TABLE 69 CANADA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 74

TABLE 70 SOUTH AMERICA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 74

TABLE 71 SOUTH AMERICA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 72 SOUTH AMERICA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 73 SOUTH AMERICA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 75

TABLE 74 SOUTH AMERICA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 75 SOUTH AMERICA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 76 SOUTH AMERICA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 77 SOUTH AMERICA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 78 SOUTH AMERICA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 76

TABLE 79 SOUTH AMERICA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 77

TABLE 80 EUROPE: CREATININE TEST MARKET, BY REGION, 2020–2027 (USD MILLION) 78

TABLE 81 EUROPE: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 78

TABLE 82 EUROPE CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 79

TABLE 83 EUROPE CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 79

TABLE 84 EUROPE: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 79

TABLE 85 EUROPE: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 79

TABLE 86 EUROPE: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 87 EUROPE: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 88 EUROPE: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 89 EUROPE: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 81

TABLE 90 EUROPE: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 81

TABLE 91 WESTERN EUROPE: CREATININE TEST MARKET, BY REGION, 2020–2027 (USD MILLION) 82

TABLE 92 WESTERN EUROPE: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 82

TABLE 93 WESTERN EUROPE CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 94 WESTERN EUROPE CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 95 WESTERN EUROPE: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 83

TABLE 96 WESTERN EUROPE: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 97 WESTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 98 WESTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 84

TABLE 99 WESTERN EUROPE: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 84

TABLE 100 WESTERN EUROPE: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 84

TABLE 101 WESTERN EUROPE: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 85

TABLE 102 GERMANY: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 85

TABLE 103 GERMANY CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 85

TABLE 104 GERMANY CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 105 GERMANY: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 86

TABLE 106 GERMANY: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 107 GERMANY: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 108 GERMANY: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 109 GERMANY: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 110 GERMANY: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 87

TABLE 111 GERMANY: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 88

TABLE 112 FRANCE: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 88

TABLE 113 FRANCE CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 88

TABLE 114 FRANCE CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 115 FRANCE: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 89

TABLE 116 FRANCE: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 117 FRANCE: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 118 FRANCE: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 90

TABLE 119 FRANCE: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 90

TABLE 120 FRANCE: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 90

TABLE 121 FRANCE: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 91

TABLE 122 UK: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 91

TABLE 123 UK: CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 91

TABLE 124 UK: CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 92

TABLE 125 UK: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 92

TABLE 126 UK: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 92

TABLE 127 UK: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 92

TABLE 128 UK: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 129 UK: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 130 UK: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 93

TABLE 131 UK: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 94

TABLE 132 ITALY: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 94

TABLE 133 ITALY: CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 94

TABLE 134 ITALY: CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 135 ITALY: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 95

TABLE 136 ITALY: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 137 ITALY: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 138 ITALY: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 96

TABLE 139 ITALY: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 96

TABLE 140 ITALY: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 96

TABLE 141 ITALY: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 97

TABLE 142 SPAIN: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 97

TABLE 143 SPAIN CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 97

TABLE 144 SPAIN CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 98

TABLE 145 SPAIN: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 98

TABLE 146 SPAIN: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 98

TABLE 147 SPAIN: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 98

TABLE 148 SPAIN: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 99

TABLE 149 SPAIN: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 99

TABLE 150 SPAIN: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 99

TABLE 151 SPAIN: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 100

TABLE 152 REST OF WESTERN EUROPE: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 100

TABLE 153 REST OF WESTERN EUROPE CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 100

TABLE 154 REST OF WESTERN EUROPE CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 101

TABLE 155 REST OF WESTERN EUROPE: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 101

TABLE 156 REST OF WESTERN EUROPE: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 101

TABLE 157 REST OF WESTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 101

TABLE 158 REST OF WESTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 102

TABLE 159 REST OF WESTERN EUROPE: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 102

TABLE 160 REST OF WESTERN EUROPE: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 102

TABLE 161 REST OF WESTERN EUROPE: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 103

TABLE 162 EASTERN EUROPE: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 103

TABLE 163 EASTERN EUROPE CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 103

TABLE 164 EASTERN EUROPE CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 104

TABLE 165 EASTERN EUROPE: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 104

TABLE 166 EASTERN EUROPE: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 104

TABLE 167 EASTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 104

TABLE 168 EASTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 105

TABLE 169 EASTERN EUROPE: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 105

TABLE 170 EASTERN EUROPE: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 105

TABLE 171 EASTERN EUROPE: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 106

TABLE 172 ASIA-PACIFIC: CREATININE TEST MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 107

TABLE 173 ASIA-PACIFIC: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 108

TABLE 174 ASIA-PACIFIC CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 108

TABLE 175 ASIA-PACIFIC CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 109

TABLE 176 ASIA-PACIFIC: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 109

TABLE 177 ASIA-PACIFIC: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 109

TABLE 178 ASIA-PACIFIC: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 109

TABLE 179 ASIA-PACIFIC: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 110

TABLE 180 ASIA-PACIFIC: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 110

TABLE 181 ASIA-PACIFIC: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 110

TABLE 182 ASIA-PACIFIC: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 111

TABLE 183 JAPAN: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 111

TABLE 184 JAPAN CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 111

TABLE 185 JAPAN CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 112

TABLE 186 JAPAN: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 112

TABLE 187 JAPAN: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 112

TABLE 188 JAPAN: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112

TABLE 189 JAPAN: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 113

TABLE 190 JAPAN: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 113

TABLE 191 JAPAN: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 113

TABLE 192 JAPAN: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 114

TABLE 193 CHINA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 114

TABLE 194 CHINA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 114

TABLE 195 CHINA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 115

TABLE 196 CHINA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 115

TABLE 197 CHINA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 115

TABLE 198 CHINA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 115

TABLE 199 CHINA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 116

TABLE 200 CHINA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 116

TABLE 201 CHINA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 116

TABLE 202 CHINA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 117

TABLE 203 INDIA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 117

TABLE 204 INDIA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 117

TABLE 205 INDIA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 118

TABLE 206 INDIA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 118

TABLE 207 INDIA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 118

TABLE 208 INDIA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 118

TABLE 209 INDIA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 119

TABLE 210 INDIA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 119

TABLE 211 INDIA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 119

TABLE 212 INDIA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 120

TABLE 213 AUSTRALIA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 120

TABLE 214 AUSTRALIA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 120

TABLE 215 AUSTRALIA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 121

TABLE 216 AUSTRALIA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 121

TABLE 217 AUSTRALIA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 121

TABLE 218 AUSTRALIA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121

TABLE 219 AUSTRALIA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 122

TABLE 220 AUSTRALIA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 122

TABLE 221 AUSTRALIA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 122

TABLE 222 AUSTRALIA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 123

TABLE 223 SOUTH KOREA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 123

TABLE 224 SOUTH KOREA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 123

TABLE 225 SOUTH KOREA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 124

TABLE 226 SOUTH KOREA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 124

TABLE 227 SOUTH KOREA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 124

TABLE 228 SOUTH KOREA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 124

TABLE 229 SOUTH KOREA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 125

TABLE 230 SOUTH KOREA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 125

TABLE 231 SOUTH KOREA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 125

TABLE 232 SOUTH KOREA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 126

TABLE 233 REST OF ASIA-PACIFIC: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 126

TABLE 234 REST OF ASIA-PACIFIC CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 126

TABLE 235 REST OF ASIA-PACIFIC CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 127

TABLE 236 REST OF ASIA-PACIFIC: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 127

TABLE 237 REST OF ASIA-PACIFIC: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 127

TABLE 238 REST OF ASIA-PACIFIC: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 127

TABLE 239 REST OF ASIA-PACIFIC: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 128

TABLE 240 REST OF ASIA-PACIFIC: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 128

TABLE 241 REST OF ASIA-PACIFIC: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 128

TABLE 242 REST OF ASIA-PACIFIC: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 129

TABLE 243 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET, BY REGION, 2020–2027 (USD MILLION) 130

TABLE 244 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 131

TABLE 245 THE MIDDLE EAST AND AFRICA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 131

TABLE 246 THE MIDDLE EAST AND AFRICA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 131

TABLE 247 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 131

TABLE 248 THE MIDDLE EAST AND AFRICA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 132

TABLE 249 THE MIDDLE EAST AND AFRICA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 132

TABLE 250 THE MIDDLE EAST AND AFRICA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 132

TABLE 251 THE MIDDLE EAST AND AFRICA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 132

TABLE 252 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 133

TABLE 253 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 133

TABLE 254 MIDDLE EAST: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 134

TABLE 255 MIDDLE EAST CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 134

TABLE 256 MIDDLE EAST CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 134

TABLE 257 MIDDLE EAST: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 135

TABLE 258 MIDDLE EAST: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 135

TABLE 259 MIDDLE EAST: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 135

TABLE 260 MIDDLE EAST: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 135

TABLE 261 MIDDLE EAST: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 136

TABLE 262 MIDDLE EAST: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 136

TABLE 263 MIDDLE EAST: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 136

TABLE 264 AFRICA: CREATININE TEST MARKET BY TEST TYPE, 2020–2027 (USD MILLION) 137

TABLE 265 AFRICA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2020–2027 (USD MILLION) 137

TABLE 266 AFRICA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2020–2027 (USD MILLION) 137

TABLE 267 AFRICA: CREATININE TEST MARKET BY PRODUCT TYPE, 2020–2027 (USD MILLION) 138

TABLE 268 AFRICA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 138

TABLE 269 AFRICA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 138

TABLE 270 AFRICA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2020–2027 (USD MILLION) 138

TABLE 271 AFRICA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2020–2027 (USD MILLION) 139

TABLE 272 AFRICA: CREATININE TEST MARKET BY APPLICATION, 2020–2027 (USD MILLION) 139

TABLE 273 AFRICA: CREATININE TEST MARKET BY END USER, 2020–2027 (USD MILLION) 139

TABLE 274 GLOBAL CREATININE TEST MARKET: KEY DEVELOPMENT 143

17 List Of Figures

FIGURE 1 GLOBAL CREATININE TEST MARKET: MARKET STRUCTURE 24

FIGURE 2 RESEARCH PROCESS OF MRFR 26

FIGURE 3 TOP DOWN & BOTTOM UP APPROACH 29

FIGURE 4 MARKET DYNAMICS ANALYSIS OF GLOBAL CREATININE TEST MARKET 31

FIGURE 5 SUPPLY CHAIN: CREATININE TEST MARKET 36

FIGURE 6 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL CREATININE TEST MARKET 38

FIGURE 7 GLOBAL CREATININE TEST MARKET, BY TEST TYPE, 2020 (%) 41

FIGURE 8 GLOBAL CREATININE TEST MARKET, BY TEST TYPE, 2020 & 2027 (USD MILLION) 42

FIGURE 9 GLOBAL CREATININE TEST MARKET, BY PRODUCT TYPE, 2020 (%) 46

FIGURE 10 GLOBAL CREATININE TEST MARKET, BY PRODUCT TYPE, 2020 & 2027 (USD MILLION) 46

FIGURE 11 GLOBAL CREATININE TEST MARKET, BY APPLICATION, 2020 (%) 51

FIGURE 12 GLOBAL CREATININE TEST MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 52

FIGURE 13 GLOBAL CREATININE TEST MARKET, BY END USER, 2020 (%) 55

FIGURE 14 GLOBAL CREATININE TEST MARKET, BY END USER, 2020 & 2027 (USD MILLION) 56

FIGURE 15 GLOBAL CREATININE TEST MARKET, BY REGION, 2020 & 2027 (USD MILLION) 59

FIGURE 16 GLOBAL CREATININE TEST MARKET, BY REGION, 2020 (%) 60

FIGURE 17 AMERICAS: CREATININE TEST MARKET SHARE, BY REGION, 2020 (%) 61

FIGURE 18 EUROPE: CREATININE TEST MARKET SHARE, BY REGION, 2020 (%) 78

FIGURE 19 ASIA-PACIFIC: CREATININE TEST MARKET SHARE, BY COUNTRY, 2020 (%) 107

FIGURE 20 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET SHARE, BY REGION, 2020 (%) 130

FIGURE 21 GLOBAL CREATININE TEST MARKET, MARKET SHARE ANALYSIS 2020 (%) 141

FIGURE 22 GLOBAL CREATININE TEST MARKET: COMPETITIVE LANDSCAPE 2020 (%) 142

Global Creatinine Test Market: Competitive Landscape


Siemens AG, Abbott Diagnostics Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche AG, and The Danaher Corporation collectively accounted for more than 70.5% market share of the global creatinine test market in 2016. These companies continue to retain their strong global presence through acquisitions and product launches.


In 2016, Siemens accounted for the largest market share of the global creatinine test market, with more than 21.2% of the market share. The large share of the company is attributed to the high demand for creatinine testing globally. Moreover, this company offers various new products in the creatinine test market. For instance, in 2018, Siemens Healthineers received an FDA approval for its Blood Urea Nitrogen (BUN) and Total Carbon Dioxide (TCO2) point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances.


Abbott held the second position in terms of market share, in 2016. The company focuses on delivering integrated solutions to large healthcare customers. Also, the company is focusing on acquisitions for establishing a strong position in the market. For instance, in Oct 2017, Abbott completed the acquisition of Alere Inc. for USD 5.3 Billion. The acquisition will establish a strong position of Abbott in the diagnostics market.


Thermo Fisher Scientific Inc. acquired the third spot in the market. The company follows a strategy of introducing a strong product portfolio at lower costs which help them to retain the position in the market.



  1. Hoffmann-La Roche AG holds the fourth place in the market owing to the strategy of identifying & developing promising technologies and potential products and focusing on merging and acquisitions with other groups to develop and identify new products and technologies. For instance, in Nov 2017, Roche announced to acquire Viewics, Inc. to expand its leading position in the Integrated Core Lab with business analytics capabilities.


The Danaher Corporation is a global technology and science innovator focusing on helping their customers solve complex challenges and improve quality of life around the world. It holds the fifth position in the global creatinine test market owing to new launches and global presence in the market. In 2017, the company announced the launch of its CE-marked point-of-care tests for creatinine and urea, the latest additions to the ABL90 FLEX PLUS blood gas analyzer’s test menu.


There are many other players present in the market such as ARKRAY, Inc., Quest Diagnostics Inc., URIT Medical, OPTI Medical Systems, Inc., ACON Laboratories, Inc., Nova Biomedical, Abcam plc, and others which accounts cumulatively for nearly 29.5% of the global market share. The companies are adopting the strategy of product launches and acquisitions to solidify their position in the market. New product developments are a key focus area for players.